Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer

The epidermal growth factor receptor (EGFR) is commonly expressed in non-small-cell lung cancer (NSCLC) and promotes a host of mechanisms involved in tumorigenesis. However, EGFR expression does not reliably predict prognosis or response to EGFR-targeted therapies. The data from two previous studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Swinson, D E B, Cox, G, O'Byrne, K J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409909/
https://www.ncbi.nlm.nih.gov/pubmed/15365565
http://dx.doi.org/10.1038/sj.bjc.6602149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409909/
https://www.ncbi.nlm.nih.gov/pubmed/15365565
http://dx.doi.org/10.1038/sj.bjc.6602149

Ejemplares similares